Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease
Authors:
- Astrid RasmussenARAstrid Rasmussen
- Elisa AlonsoEAElisa Alonso
- Adriana OchoaAOAdriana Ochoa
- Irene De BiaseIBIrene De Biase
- Itziar FamiliarIFItziar Familiar
- Petra YescasPYPetra Yescas
- Ana-Luisa SosaASAna-Luisa Sosa
- Yaneth RodríguezYRYaneth Rodríguez
- Mireya ChávezMCMireya Chávez
- Marisol López-LópezMLMarisol López-López
- Sanjay I BidichandaniSBSanjay I Bidichandani
Open Access
- 12 January 2010
- journal article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 11 (1) , 4
Abstract
Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome caused by germline mutations in the VHL gene. Patients have significant morbidity and mortality secondary to vascular tumors. Disease management is centered on tumor surveillance that allows early detection and treatment. Presymptomatic genetic testing is therefore recommended, including in at-risk children.Keywords
This publication has 32 references indexed in Scilit:
- Presymptomatic Diagnosis in Huntington's Disease: The Mexican ExperienceGenetic Testing and Molecular Biomarkers, 2009
- Clinical and genetic characteristics of Mexican Huntington's disease patientsMovement Disorders, 2009
- Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testingJournal of Medical Genetics, 2007
- Patient preferences regarding recontact by cancer genetics cliniciansFamilial Cancer, 2007
- Familial adenomatous polyposis: the practical applications of clinical and molecular screeningFamilial Cancer, 2006
- Genetics as a tool to improve cancer outcomes: ethics and policyNature Reviews Cancer, 2006
- Von Hippel–Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastomaJournal of Neurosurgery, 2006
- American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer SusceptibilityJournal of Clinical Oncology, 2003
- Psychological risks of genetically testing children for a hereditary cancer syndromePatient Education and Counseling, 1997
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993